Assignee
ALLERGAN SALES INC
US·196 granted patents·39 pending applications·14,145 citations·filing 1992–2004
Top patents by PatentIndex Score
235 records- 0199US6506399B2Biodegradable botulinum toxin implantALLERGAN SALES INC·Filed 2001·Granted Jan 14, 2003·724 cites·20 claims
- 0299US6403649B1Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agentsALLERGAN SALES INC·Filed 2000·Granted Jun 11, 2002·272 cites·3 claims
- 0399US6383509B1Biodegradable neurotoxin implantALLERGAN SALES INC·Filed 2001·Granted May 7, 2002·313 cites·18 claims
- 0499US6312708B1Botulinum toxin implantALLERGAN SALES INC·Filed 2000·Granted Nov 6, 2001·437 cites·20 claims
- 0599US6306423B1Neurotoxin implantALLERGAN SALES INC·Filed 2000·Granted Oct 23, 2001·566 cites·20 claims
- 0699US6143306AMethods for treating pancreatic disordersALLERGAN SALES INC·Filed 2000·Granted Nov 7, 2000·196 cites·30 claims
- 0799US6139845AMethod for treating cancer with a neurotoxinALLERGAN SALES INC·Filed 1999·Granted Oct 31, 2000·360 cites·13 claims
- 0899US6113915AMethods for treating painALLERGAN SALES INC·Filed 1999·Granted Sep 5, 2000·295 cites·36 claims
- 0999US5919970ASubstituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activityALLERGAN SALES INC·Filed 1997·Granted Jul 6, 1999·227 cites·19 claims
- 1098US6423319B1Methods for treating muscle injuriesALLERGAN SALES INC·Filed 2000·Granted Jul 23, 2002·226 cites·11 claims
- 1198US6358926B2Neurotoxin therapy for inner ear disordersALLERGAN SALES INC·Filed 2001·Granted Mar 19, 2002·156 cites·19 claims
- 1298US6350442B2Ocular treatment using cyclosporin-A derivativesALLERGAN SALES INC·Filed 2001·Granted Feb 26, 2002·151 cites·7 claims
- 1398US6306403B1Method for treating parkinson's disease with a botulinum toxinALLERGAN SALES INC·Filed 2000·Granted Oct 23, 2001·180 cites·17 claims
- 1498US6265379B1Method for treating otic disordersALLERGAN SALES INC·Filed 1999·Granted Jul 24, 2001·258 cites·11 claims
- 1598US6037364ACyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agentsALLERGAN SALES INC·Filed 1999·Granted Mar 14, 2000·67 cites·26 claims
- 1697US6869610B2Pain treatment by peripheral administration of a neurotoxinALLERGAN SALES INC·Filed 2002·Granted Mar 22, 2005·89 cites·7 claims
- 1797US6645496B2Method for treating tardive dyskinesia with Botulinum toxin type BALLERGAN SALES INC·Filed 2001·Granted Nov 11, 2003·63 cites·8 claims
- 1897US6447785B1Method for treating hypercalcemiaALLERGAN SALES INC·Filed 2000·Granted Sep 10, 2002·62 cites·8 claims
- 1997US6329369B1Methods of treating pain and other conditionsALLERGAN SALES INC·Filed 2000·Granted Dec 11, 2001·83 cites·17 claims
- 2097US6328977B1Method for treating hyperparathyroidismALLERGAN SALES INC·Filed 2000·Granted Dec 11, 2001·93 cites·10 claims
- 2197US6319505B1Method for treating dystonia with botulinum toxin types C to GALLERGAN SALES INC·Filed 2000·Granted Nov 20, 2001·67 cites·3 claims
- 2297US6306426B1Implant device with a retinoid for improved biocompatibilityALLERGAN SALES INC·Filed 2000·Granted Oct 23, 2001·136 cites·10 claims
- 2397US6261572B1Method for treating a pancreatic disorder with a neurotoxinALLERGAN SALES INC·Filed 2000·Granted Jul 17, 2001·133 cites·13 claims
- 2497US6248741B1Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injuryALLERGAN SALES INC·Filed 2000·Granted Jun 19, 2001·98 cites·11 claims
- 2597US6194415B1Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injuryALLERGAN SALES INC·Filed 1999·Granted Feb 27, 2001·168 cites·6 claims
- 2697US6124344ACyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agentsALLERGAN SALES INC·Filed 1997·Granted Sep 26, 2000·75 cites·24 claims
- 2797US5877207ASynthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN SALES INC·Filed 1997·Granted Mar 2, 1999·245 cites·34 claims
- 2896US6358513B1Method for treating Hashimoto's thyroiditisALLERGAN SALES INC·Filed 2000·Granted Mar 19, 2002·104 cites·11 claims
- 2996US6254860B1Ocular treatment using cyclosporin-A derivativesALLERGAN SALES INC·Filed 1999·Granted Jul 3, 2001·146 cites·10 claims
- 3096US6204287B1Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agentsALLERGAN SALES INC·Filed 2000·Granted Mar 20, 2001·46 cites·9 claims
- 3196US6074661ASterile bioerodible occular implant device with a retinoid for improved biocompatabilityALLERGAN SALES INC·Filed 1998·Granted Jun 13, 2000·306 cites·3 claims
- 3296US5958954ASynthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN SALES INC·Filed 1997·Granted Sep 28, 1999·176 cites·46 claims
- 3396US5917082A2,4-pentadienoic acid derivatives having retinoid-like biological activityALLERGAN SALES INC·Filed 1997·Granted Jun 29, 1999·86 cites·3 claims
- 3495US6410544B1Cholinergic agents in the treatment of presbyopiaALLERGAN SALES INC·Filed 2001·Granted Jun 25, 2002·74 cites·13 claims
- 3595US6406494B1Moveable intraocular lensALLERGAN SALES INC·Filed 2000·Granted Jun 18, 2002·288 cites·28 claims
- 3695US6291677B1Compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2000·Granted Sep 18, 2001·51 cites·13 claims
- 3795US6090810ASynthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN SALES INC·Filed 1998·Granted Jul 18, 2000·59 cites·38 claims
- 3895US5952345ASynthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN SALES INC·Filed 1997·Granted Sep 14, 1999·83 cites·31 claims
- 3994US6641834B2Compositions containing alpha-2-adrenergic agonist componentsALLERGAN SALES INC·Filed 2002·Granted Nov 4, 2003·58 cites·22 claims
- 4094US6294553B1Method for treating ocular painALLERGAN SALES INC·Filed 2001·Granted Sep 25, 2001·52 cites·11 claims
- 4194US6211385B1Process for preparing substituted benzo[1,2-G]-chrome-3-ene, benzo[1,2-G]-thiochrom-3-ene and benzo[1,2-G]-1,2-dihydroquinoline derivativesALLERGAN SALES INC·Filed 2000·Granted Apr 3, 2001·36 cites·15 claims
- 4294US6008204ASynthesis and use of retinoid compounds having negative hormone and/or antagonist activitiesALLERGAN SALES INC·Filed 1998·Granted Dec 28, 1999·55 cites·10 claims
- 4393US6416765B1Neurotoxin therapy for diabetesALLERGAN SALES INC·Filed 2001·Granted Jul 9, 2002·41 cites·25 claims
- 4493US6394974B1Power mode phacoALLERGAN SALES INC·Filed 1999·Granted May 28, 2002·87 cites·11 claims
- 4593US6387950B2Treatment of tumors with RARα selective retinoid compounds in combination with other anti-tumor agentsALLERGAN SALES INC·Filed 2001·Granted May 14, 2002·65 cites·28 claims
- 4693US6372226B2Intraspinal botulinum toxin for treating painALLERGAN SALES INC·Filed 2001·Granted Apr 16, 2002·37 cites·6 claims
- 4793US6333037B1Methods for treating pain with a modified neurotoxinALLERGAN SALES INC·Filed 2000·Granted Dec 25, 2001·39 cites·36 claims
- 4893US6313107B1Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAIALLERGAN SALES INC·Filed 2000·Granted Nov 6, 2001·44 cites·21 claims
- 4992US6545182B2Methods and compositions for modulating alpha adrenergic receptor activityALLERGAN SALES INC·Filed 2001·Granted Apr 8, 2003·79 cites·15 claims
- 5092US6410591B13,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressureALLERGAN SALES INC·Filed 2001·Granted Jun 25, 2002·40 cites·15 claims
Showing the top 50 of 235 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ALLERGAN SALES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →